These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33098639)

  • 21. miR-325-3p Overexpression Inhibits Proliferation and Metastasis of Bladder Cancer Cells by Regulating MT3.
    Sun S; Liu F; Xian S; Cai D
    Med Sci Monit; 2020 Jun; 26():e920331. PubMed ID: 32512576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-506 suppresses tumor proliferation and invasion by targeting FOXQ1 in nasopharyngeal carcinoma.
    Zhang Z; Ma J; Luan G; Kang L; Su Y; He Y; Luan F
    PLoS One; 2015; 10(4):e0122851. PubMed ID: 25856555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circular RNA circFLNA inhibits the development of bladder carcinoma through microRNA miR-216a-3p/BTG2 axis.
    Lin S; Wang L; Shi Z; Zhu A; Zhang G; Hong Z; Cheng C
    Bioengineered; 2021 Dec; 12(2):11376-11389. PubMed ID: 34852712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. circSOBP Inhibits Bladder Cancer Proliferation and Metastasis by Regulating the miR-200a-3p/PTEN Axis and Participating in the Immune Response.
    Zhang Y; Li Z; Zhang Y; Shen C; Zhang Z; Ren X; Guo C; Yang S; Wang Z; Hu H
    Cell Transplant; 2023; 32():9636897231165874. PubMed ID: 37026617
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.
    Yang R; Liu M; Liang H; Guo S; Guo X; Yuan M; Lian H; Yan X; Zhang S; Chen X; Fang F; Guo H; Zhang C
    Mol Cancer; 2016 Dec; 15(1):82. PubMed ID: 27978829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of miR-519d-3p is Associated with Poor Outcomes and Facilitates Tumor Progression in Papillary Thyroid Cancer by Regulating FOXQ1.
    Li P; Pan X; Zheng Z; Sun Y; Han Y; Dong J; Lu M
    Horm Metab Res; 2021 Sep; 53(9):625-632. PubMed ID: 34496413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
    IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA TUG1 promotes bladder cancer malignant behaviors by regulating the miR-320a/FOXQ1 axis.
    Tan J; Liu B; Zhou L; Gao J; Wang XK; Liu Y; Wang JR
    Cell Signal; 2022 Mar; 91():110216. PubMed ID: 34920123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD.
    Yu G; Jia Z; Dou Z
    Oncol Rep; 2017 Feb; 37(2):1123-1131. PubMed ID: 28000900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-130b promotes bladder cancer cell proliferation, migration and invasion by targeting VGLL4.
    Liu X; Kong C; Zhang Z
    Oncol Rep; 2018 May; 39(5):2324-2332. PubMed ID: 29512748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-621 inhibits cell proliferation and metastasis in bladder cancer by suppressing Wnt/β-catenin signaling.
    Tian H; Wang X; Lu J; Tian W; Chen P
    Chem Biol Interact; 2019 Aug; 308():244-251. PubMed ID: 31145890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-1-3p Suppresses the Proliferation, Invasion and Migration of Bladder Cancer Cells by Up-Regulating SFRP1 Expression.
    Shang A; Yang M; Shen F; Wang J; Wei J; Wang W; Lu W; Wang C; Wang C
    Cell Physiol Biochem; 2017; 41(3):1179-1188. PubMed ID: 28268231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-1-3p inhibits the proliferation and invasion of bladder cancer cells by suppressing CCL2 expression.
    Wang W; Shen F; Wang C; Lu W; Wei J; Shang A; Wang C
    Tumour Biol; 2017 Jun; 39(6):1010428317698383. PubMed ID: 28618950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA ARAP1-AS1 promotes the progression of bladder cancer by regulating miR-4735-3p/NOTCH2 axis.
    Teng J; Ai X; Jia Z; Wang K; Guan Y; Guo Y
    Cancer Biol Ther; 2019; 20(4):552-561. PubMed ID: 30404578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met.
    Xu X; Chen H; Lin Y; Hu Z; Mao Y; Wu J; Xu X; Zhu Y; Li S; Zheng X; Xie L
    Mol Cells; 2013 Jul; 36(1):62-8. PubMed ID: 23820886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-454-3p and miR-374b-5p suppress migration and invasion of bladder cancer cells through targetting ZEB2.
    Wang S; Zhang G; Zheng W; Xue Q; Wei D; Zheng Y; Yuan J
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting β-catenin and CDK2 and activating p21.
    Zhang Q; Miao S; Han X; Li C; Zhang M; Cui K; Xiong T; Chen Z; Wang C; Xu H
    Cell Death Dis; 2018 Sep; 9(10):960. PubMed ID: 30237499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
    Vishnubalaji R; Hamam R; Yue S; Al-Obeed O; Kassem M; Liu FF; Aldahmash A; Alajez NM
    Oncotarget; 2016 Jun; 7(24):35789-35802. PubMed ID: 27119506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals.
    Deng G; Wang R; Sun Y; Huang CP; Yeh S; You B; Feng C; Li G; Ma S; Chang C
    Cell Death Differ; 2021 Jul; 28(7):2145-2159. PubMed ID: 34127806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysregulation and prometastatic function of glycosyltransferase C1GALT1 modulated by cHP1BP3/ miR-1-3p axis in bladder cancer.
    Tan Z; Jiang Y; Liang L; Wu J; Cao L; Zhou X; Song Z; Ye Z; Zhao Z; Feng H; Dong Z; Lin S; Zhou Z; Wang Y; Li X; Guan F
    J Exp Clin Cancer Res; 2022 Jul; 41(1):228. PubMed ID: 35864552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.